Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News   Press Releases

Supreme Pharmaceuticals Inc. Opens the Market

June 13, 2017

Canada NewsWire

TORONTO, June 13, 2017

TORONTO, June 13, 2017 /CNW/ - John Fowler, President & CEO, Supreme Pharmaceuticals Inc. (FIRE), joined Brady Fletcher, Managing Director, TSX Venture Exchange, to open the market. Supreme Pharmaceuticals is a cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations operating inside a 342,000 sq. ft. Hybrid Greenhouse facility. Supreme Pharmaceuticals Inc. commenced trading on TSX Venture Exchange on June 6, 2017.

John Fowler, President & CEO, Supreme Pharmaceuticals Inc. (FIRE), joined Brady Fletcher, Managing Director, TSX Venture Exchange, to open the market. Supreme Pharmaceuticals is a cultivator and distributor of sun grown cannabis through its wholly-owned subsidiary 7ACRES. 7ACRES is a federally licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations operating inside a 342,000 sq. ft. Hybrid Greenhouse facility. Supreme Pharmaceuticals Inc. commenced trading on TSX Venture Exchange on June 6, 2017. (CNW Group/TMX Group Limited)

SOURCE TMX Group Limited

View original content with multimedia: http://www.newswire.ca/en/releases/archive/June2017/13/c6237.html

Related News

Recent U.S. Press Releases

More Press Releases »

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today